May Measurement Month 2019: an analysis of blood pressure screening results from Poland.

Blood pressure Control Disease awareness Hypertension Screening Treatment

Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 12 7 2021
pubmed: 13 7 2021
medline: 13 7 2021
Statut: epublish

Résumé

May Measurement Month 2019 is the third edition of a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for blood pressure (BP) screening. We present data analysis from Poland. To evaluate the potential of opportunistic BP measurements as a tool for cardiovascular disease prevention programmes. To collect new country data for further annual comparisons. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in 201 sites in May 2019. BP was measured in 7072 subjects (mean age: 54 ± 15 years; 62.3% females). After multiple imputation, the age- and sex-standardized systolic BP (SBP) and diastolic BP (DBP) was 125.4/78.5 mmHg in the whole group, 133.3/82.8 mmHg in individuals on antihypertensive medication and 123.3/77.7 mmHg in those not taking antihypertensive drugs. The proportion of subjects with high BP (≥140/90 mmHg) were 41.8% in subjects taking antihypertensive drugs, and 19.6% in those not taking any antihypertensive drugs. Overall, hypertension was present in 55.4% of participants (3917 out of 7072), of whom 83.0% were aware of their diagnosis. 80.4% of hypertensives were taking antihypertensive medication. 46.7% of all hypertensives had BP controlled to target (<140/90 mmHg). Higher BP correlated with body mass index and age but not tobacco smoking. SBP but not DBP was higher in diabetic participants. These data provide evidence on the current epidemiology of hypertension and may serve as a source of information to introduce primary and secondary prevention programmes to reduce cardiovascular risk in Poland.

Identifiants

pubmed: 34248436
doi: 10.1093/eurheartj/suab045
pii: suab045
pmc: PMC8263086
doi:

Types de publication

Journal Article

Langues

eng

Pagination

B124-B127

Informations de copyright

Published on behalf of the European Society of Cardiology. © The Author(s) 2021.

Références

Eur Heart J Suppl. 2020 Aug;22(Suppl H):H108-H111
pubmed: 32884486
Hypertension. 2020 Aug;76(2):333-341
pubmed: 32419505
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Lancet Glob Health. 2018 Jul;6(7):e736-e743
pubmed: 29778399
Lancet. 2020 Oct 17;396(10258):1160-1203
pubmed: 33069325
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
Eur Heart J Suppl. 2019 Apr;21(Suppl D):D97-D100
pubmed: 31043891
Arch Med Sci. 2018 Aug;14(5):951-961
pubmed: 30154875
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326

Auteurs

Anna Sęk-Mastej (A)

Department of Morphological Sciences, Collegium of Medical Sciences, University of Rzeszów, Czarnego 4, 35-615 Rzeszów, Poland.

Maciej Banach (M)

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Żeromskiego 113, 90-549 Łódź, Poland.

Mirosław Mastej (M)

Mastej Medical Center, Staszica 21, 38-200 Jasło, Poland.

Piotr Jankowski (P)

I Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, 31-501 Kraków, Poland.

Jolanta Małyszko (J)

Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Banacha 1a, 02-097 Warszawa, Poland.

Krzysztof J Filipiak (KJ)

I Department of Cardiology, Medical University of Warsaw, 1a Banacha, 02 097 Warsaw, Poland.

Michał P Nowicki (MP)

Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Pomorska 251, 92-213 Łódź, Poland.

Tomasz Tomasik (T)

Department of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bocheńska 4, 31-061 Kraków, Poland.

Adam Windak (A)

Department of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bocheńska 4, 31-061 Kraków, Poland.

Agnieszka Olszanecka (A)

I Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, 31-501 Kraków, Poland.

Maciej Tomaszewski (M)

Division of Cardiovascular Sciences, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK.

Xin Xia (X)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Jacek Jóźwiak (J)

Department of Family Medicine and Public Health, Faculty of Medicine, University of Opole, Oleska 48, 45-052 Opole, Poland.

Classifications MeSH